Status:
UNKNOWN
Efficiency of Tadalafil for Management of Female Sexual Dysfunction
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Sexual Dysfunction
Eligibility:
FEMALE
25-35 years
Phase:
PHASE2
PHASE3
Brief Summary
comparative study between tadalafil versus placebo effect for the management of circumsized female
Detailed Description
the group of patient will be randomly divided into 2 groups, half of the patients will receive tadalafil and the other half will receive placebo
Eligibility Criteria
Inclusion
- female with history of female genital mutilation female with history of sexual dysfunction
Exclusion
- any medical disorder
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05266651
Start Date
March 10 2022
End Date
May 1 2022
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Elainy
Cairo, Egypt